These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 15718287)

  • 1. Delivery of beta-galactosidase to mouse brain via the blood-brain barrier transferrin receptor.
    Zhang Y; Pardridge WM
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1075-81. PubMed ID: 15718287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
    Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
    Jeong Lee H; Pardridge WM
    J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
    Wu D; Boado RJ; Pardridge WM
    J Pharmacol Exp Ther; 1996 Jan; 276(1):206-11. PubMed ID: 8558431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Kang YS; Bickel U; Pardridge WM
    Drug Metab Dispos; 1994; 22(1):99-105. PubMed ID: 8149897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier after conjugation to anti-transferrin receptor antibodies.
    Walus LR; Pardridge WM; Starzyk RM; Friden PM
    J Pharmacol Exp Ther; 1996 May; 277(2):1067-75. PubMed ID: 8627518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Yoshikawa T; Pardridge WM
    J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse.
    Boado RJ; Zhang Y; Wang Y; Pardridge WM
    Biotechnol Bioeng; 2009 Mar; 102(4):1251-8. PubMed ID: 18942151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
    Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker.
    Deguchi Y; Kurihara A; Pardridge WM
    Bioconjug Chem; 1999; 10(1):32-7. PubMed ID: 9893961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
    Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
    Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein.
    Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM
    Mol Pharm; 2011 Aug; 8(4):1342-50. PubMed ID: 21667973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
    Kang YS; Pardridge WM
    J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective plasma pharmacokinetics and brain uptake in the mouse of enzyme fusion proteins derived from species-specific receptor-targeted antibodies.
    Zhou QH; Boado RJ; Pardridge WM
    J Drug Target; 2012 Sep; 20(8):715-9. PubMed ID: 22845843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and blood-brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody.
    Wu D; Pardridge WM
    Drug Metab Dispos; 1998 Sep; 26(9):937-9. PubMed ID: 9733674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.
    Pardridge WM; Buciak JL; Friden PM
    J Pharmacol Exp Ther; 1991 Oct; 259(1):66-70. PubMed ID: 1920136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-specific expression of an exogenous gene after i.v. administration.
    Shi N; Zhang Y; Zhu C; Boado RJ; Pardridge WM
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12754-9. PubMed ID: 11592987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-engineering erythropoietin as an IgG fusion protein that penetrates the blood-brain barrier in the mouse.
    Zhou QH; Boado RJ; Lu JZ; Hui EK; Pardridge WM
    Mol Pharm; 2010 Dec; 7(6):2148-55. PubMed ID: 20860349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread expression of an exogenous gene in the eye after intravenous administration.
    Zhu C; Zhang Y; Pardridge WM
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3075-80. PubMed ID: 12202532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.